Nervesim™ and Brainsim™: Platforms for Neurological Drug Discovery and Toxicology

vimeo-video-thumbnail

Speakers: Helena Hogberg, PhD, Deputy Director of Center for Alternatives to Animal Testing at Johns Hopkins University Bloomberg School of Public Health and Lowry Curley, PhD, Co-Founder and CEO, AxoSim

NerveSim™ and BrainSim™ are two cutting-edge platforms that mimic the PNS and CNS. Learn about the latest research regarding NerveSim™’s ability to recapitulate peripheral neuropathy in four common chemotherapeutics and BrainSim™’s use in neurological effects of COVID-19.